Searched for
TORRENT PHARMA NEWS
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...- Stocks in news: SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis BankIndian markets saw volatile trading on Thursday, closing nearly unchanged despite positive signals. Several companies including SBI, Titan,...
- Stocks in news: Torrent Power, GAIL, J&K Bank, Ola Electric, Vedanta, InfosysMarkets ended higher for the third consecutive session amidst volatility. Today's trade will focus on ceasefire developments and the MPC me...
- Torrent Pharma shares in focus after CCI clears Rs 19,500 crore acquisition of JB ChemicalsTorrent Pharmaceuticals shares are expected to see activity. The Competition Commission of India has approved Torrent Pharma's plan to acqu...
- Torrent Pharma shares surge 4% after agreeing to acquire JB Chemicals for Rs 11,900 croreTorrent Pharmaceuticals will acquire a controlling stake in J.B. Chemicals. The deal is worth Rs 11,917 crore. Torrent Pharma approved the ...
- Stocks in news: L&T, Tata Power, Dabur, Marico, Torrent PharmaShares of Torrent Pharmaceuticals are expected to remain in focus on Wednesday as the company's promoter could sell 2.9% stake worth Rs 3,0...
- Stocks in news: BHEL, Chetan Rajpara, Kalpataru Projects, Torrent Pharma, Century TextilesIndian equity markets are witnessing dynamic movements with substantial swings. Shares of BHEL, Chetan Rajpara, Kalpataru Projects, Torrent...
- Torrent Pharma board approves to raise Rs 5,000 croreTorrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical ...
- Buy Torrent Pharma, target price Rs 2362: BNP ParibasTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 79292.69 Crore) operating in...
- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Torrent Pharma calls the reports of Cipla acquisition as speculative"As a policy we don't want to comment on speculative news," said Sudhir Menon, CFO of Torrent Pharma, referring to reports about the race t...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Torrent Pharma Q1 Results: Profit rises 7% YoY to Rs 378 croreThe earnings before interest, tax, depreciation and amortisation (EBITDA) 11% YoY to Rs 791 crore. The R&D spend rose 6% YoY to Rs 129 cror...
- Torrent Pharma shares jump 8% on strong Q4 earnings. How to trade stock now?Torrent Pharmaceuticals' shares surged 8% after the company reported a profit of INR 287 crore ($38.4m) during Q4 FY22, compared to a net l...
- Torrent Pharma Q2 Results: Firm posts 1% drop in PAT to Rs 312 croreRevenues rose 7% YoY to Rs 2,291 crore during Q2FY23
- Torrent Pharma Q2 Results: Firm posts 1% drop in net profit to Rs 312 croreRevenues rose 7% YoY to Rs 2,291 crore during Q2FY23, compared to Rs 2,137 crore in Q2FY22.
- Torrent Pharma tanks 15% after disappointing Q3 numbersThe drugmaker said its consolidated net profit declined by 16 per cent to Rs 249 crore for the quarter ended December 2021. The company had...
- Cadila Healthcare, Torrent Pharma eyeing potential merger"More clarity on the proposed structure, valuations can be expected in the next six months," a source said adding that the merger may or ma...
- Elder Pharma crashes 8% on worry about residual business; Torrent down 4%The deal is a not a good one for anybody to go in for right now, rather investors could go for a growth stocks like Lupin, Aurobindo and Bi...
Load More
